Villeni, Baby Boy .
HRN: 27-51-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/18/2025
07/25/2025
IV
42mg
OD
PSNB
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified SepsisProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes